Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1833 News Items found Meet Rebecca Delconte, Winner of the 2021-2022 Parker Institute-MSK Postdoctoral Fellowship Wednesday, March 17, 2021 The PICI@MSK fellowship will provide Dr. Delconte with two years of financial support for her research on natural killer cells in cancer. MSK’s Visible Ink Writing Program Presents Two Nights of Virtual Performances Tuesday, March 16, 2021 Performers from Hamilton, Company, Harry Potter and the Cursed Child, Carmen Jones and more bring MSK patients’ stories to life on March 22 and 29. Brain Trust: 8 Questions with Ingo Mellinghoff Thursday, March 11, 2021 Ingo Mellinghoff is optimistic about the future of brain cancer treatments as the new Chair of MSK’s Department of Neurology. In the Clinic High-Dose Radiation Offers Hope for People with Inoperable Pancreatic Cancer Thursday, March 11, 2021 A high-dose radiation treatment is effective for pancreatic cancer patients who cannot have surgery. MSK Partners with Nassau County to Equitably Distribute COVID-19 Vaccines Wednesday, March 10, 2021 In partnership with the Nassau County Department of Health, MSK Nassau will help equitably distribute COVID-19 vaccinations. The National Cancer Act @ 50: The First "Cancer Centers" Monday, March 8, 2021 This year, MSK joins the National Cancer Institute and the larger cancer community in commemorating the 50th anniversary of the signing of the National Cancer Act of 1971. Women Leaders at MSK: Mini Kamboj Monday, March 8, 2021 Mini Kamboj says encouragement from her family during her early years help mold her into the strong, self-possessed leader needed to guide MSK through the COVID-19 pandemic. ‘Aren’t I Too Young?’ How MSK Helps People under 50 with Colorectal and GI Cancers Monday, March 8, 2021 Learn more about the first facility in the world devoted to the specific needs of colorectal cancer patients under the age of 50. Researchers Report Excellent Outcomes for New Leukemia and Lymphoma Drug Friday, March 5, 2021 The first-ever clinical trial of a new kind of drug, called pirtobrutinib or LOXO-305, has shown promising results in a phase I/II study. Feature In Memoriam: Developmental Biologist Kathryn V. Anderson Monday, March 1, 2021 Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment